Shares of BeyondSpring Inc.
BYSI,
+1.58%
more than tripled — up 242% — on heavy volume in premarket trading Wednesday, after the New York-headquartered biopharmaceutical company said a Phase 3 trial of its lung cancer treatment met the primary and…
BeyondSpring stock more than triples after lung cancer treatment meets endpoints in Phase 3 trial
Share this article
More News


Binance founder says crypto exchange may have been hacked
October 30, 2026
Prediction: This Will Be Broadcom’s Stock Price by the End of 2027
October 30, 2026



